Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

0ACX

Centessa Pharmaceuticals (0ACX)

Centessa Pharmaceuticals Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0ACX
DateTimeSourceHeadlineSymbolCompany
11/12/20247:00AMUK RegulatoryCentessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2024 and Provides Business UpdateLSE:0ACXCentessa Pharmaceuticals Plc
09/12/202410:34PMUK RegulatoryCentessa Pharmaceuticals Announces Pricing of Upsized $225,000,000 Public Offering of American Depositary SharesLSE:0ACXCentessa Pharmaceuticals Plc
09/11/20244:04PMUK RegulatoryCentessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary SharesLSE:0ACXCentessa Pharmaceuticals Plc
09/10/20247:00AMUK RegulatoryCentessa Announces Positive Interim Phase 1 Clinical Data with its Novel Orexin Receptor 2 (OX2R) Agonist, ORX750, in Acutely Sleep-Deprived Healthy VolunteersLSE:0ACXCentessa Pharmaceuticals Plc
08/27/20248:00AMUK RegulatoryCentessa Pharmaceuticals Announces Late-Breaking Poster Presentation of Non-Human Primate Data for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist, at the 27th Congress of the European Sleep Research Society (Sleep Europe 2024)LSE:0ACXCentessa Pharmaceuticals Plc
08/13/20247:00AMUK RegulatoryCentessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2024LSE:0ACXCentessa Pharmaceuticals Plc
 Showing the most relevant articles for your search:LSE:0ACX

Your Recent History

Delayed Upgrade Clock